See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $403B | 4.8x | 17.3x | |
| $399B | 6.9x | 15.1x | |
| $238B | 4.6x | 19.2x | |
| $178B | 2.5x | 12.1x | |
| $82.3B | 4.1x | 16.6x | |
| $68.7B | 1.3x | 6.0x | |
| $62.7B | 8.5x | 36.9x | |
| $57.7B | 3.0x | 10.6x | |
| $57.1B | 3.7x | 14.9x | |
| $49.9B | 5.3x | 21.8x | |
| $48.2B | 3.1x | 13.2x | |
| $38.7B | 2.7x | 20.1x | |
| $37.3B | 7.6x | 33.0x | |
| $33.0B | 1.3x | 7.3x | |
| $25.6B | 2.2x | 12.4x | |
| $25.4B | 4.2x | 18.1x | |
| $23.0B | 2.0x | 13.0x | |
| $22.9B | 2.3x | 6.5x | |
| $22.3B | 1.5x | 8.1x | |
| $20.1B | 1.8x | 11.9x | |
| $14.2B | 8.3x | 39.3x | |
| $12.4B | 8.3x | 32.6x | |
| $12.4B | 2.1x | 10.7x | |
| $12.1B | 2.1x | 15.0x | |
| $10.8B | 8.3x | 41.9x | |
| $10.6B | 1.5x | 8.2x | |
| $10.0B | 6.7x | 36.1x | |
| $9.0B | 1.3x | 12.7x | |
| $8.4B | 1.4x | 7.8x | |
| $7.7B | 10.8x | 33.1x | |
| $7.5B | 5.4x | 24.9x | |
| $7.0B | 1.6x | 9.2x | |
| $6.6B | 2.4x | 10.6x | |
| $6.3B | 7.2x | 17.1x | |
| $6.2B | 13.8x | 43.8x | |
| $5.7B | 1.9x | 13.4x | |
| $5.0B | 9.8x | 40.9x | |
| $4.9B | 4.3x | 13.0x | |
| $4.5B | 3.0x | 14.9x | |
| $4.3B | 1.3x | 7.3x | |
| $4.1B | 5.6x | 26.4x | |
| $4.0B | 3.8x | 26.2x | |
| $4.0B | 12.3x | 49.8x | |
| $3.9B | 2.4x | 13.0x | |
| $3.8B | 5.4x | 25.5x | |
| $3.7B | 1.7x | 11.4x | |
| $3.5B | 0.6x | 6.1x | |
| $3.3B | 3.1x | 14.1x | |
| $3.2B | 1.0x | 6.2x | |
| $3.0B | 1.4x | 8.2x | |
| $3.0B | 0.6x | 5.8x | |
| $2.8B | 6.1x | 22.7x | |
| $2.6B | 0.8x | 5.2x | |
| $2.5B | 1.1x | 7.2x | |
| $2.5B | 1.4x | 11.9x | |
| $2.4B | 0.9x | 4.7x | |
| $2.4B | 1.2x | 9.2x | |
| $2.4B | 2.1x | -99.7x | |
| $2.3B | 1.2x | 9.8x | |
| $2.3B | 0.8x | 6.8x | |
| $2.2B | 3.3x | 16.3x | |
| $2.2B | 2.6x | 17.0x | |
| $2.0B | 3.3x | 19.3x | |
| $1.9B | 4.8x | 13.5x | |
| $1.7B | 0.8x | 8.3x | |
| $1.7B | 0.9x | 6.2x | |
| $1.6B | 1.3x | 10.8x | |
| $1.6B | 2.6x | 10.8x | |
| $1.6B | 1.2x | 9.1x | |
| $1.4B | 0.6x | 5.6x | |
| $1.4B | 4.6x | 10.6x | |
| $1.1B | 1.6x | 6.6x | |
| $1.1B | 2.7x | 10.2x | |
| $1.1B | 7.8x | 27.6x | |
| $1.1B | n/a | n/a | |
| $1.1B | 4.2x | 97.2x | |
| $1.0B | 1.4x | 9.8x | |
| $935M | 0.3x | 2.2x | |
| $768M | n/a | n/a | |
| $704M | n/a | n/a | |
| $660M | 2.1x | -135.9x | |
| $615M | 1.4x | 6.5x | |
| $583M | 0.8x | 4.2x | |
| $582M | 0.8x | 6.0x | |
| $559M | 2.3x | 23.6x | |
| $531M | 0.5x | 4.9x | |
| $528M | 0.3x | n/a | |
| $515M | 1.3x | 18.8x | |
| $514M | 1.8x | 11.8x | |
| $492M | 1.2x | 8.2x | |
| $482M | 1.5x | 29.5x | |
| $464M | 3.1x | 11.9x | |
| $417M | n/a | n/a | |
| $401M | 2.0x | -27.3x | |
| $352M | n/a | n/a | |
| $335M | 1.3x | n/a | |
| $317M | 0.8x | 9.4x | |
| $280M | n/a | n/a | |
| $278M | n/a | n/a | |
| $263M | 5.4x | 20.0x | |
| $259M | 1.3x | 7.9x | |
| $210M | 0.4x | 9.3x | |
| $197M | 1.0x | 10.7x | |
| $191M | n/a | n/a | |
| $156M | n/a | n/a | |
| $144M | 0.5x | 6.0x | |
| $139M | 2.1x | 9.7x | |
| $137M | 2.3x | 7.5x | |
| $105M | n/a | n/a | |
| $94.4M | 0.4x | 5.0x | |
| $58.1M | 1.2x | 8.8x | |
| $55.3M | 2.1x | 8.6x | |
| $48.8M | n/a | n/a | |
| $43.1M | n/a | n/a | |
| $32.5M | n/a | n/a | |
| $20.7M | 0.8x | -27.8x | |
| $20.0M | 1.5x | n/a | |
| $19.7M | n/a | n/a | |
| $13.8M | n/a | n/a | |
| $13.0M | n/a | n/a | |
| $12.3M | n/a | n/a | |
| $10.3M | 0.0x | 0.5x | |
| $6.9M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| $0.5M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty